Technological Innovation
First written in FY2017-Q1. 25 of 32 entries say "Restated". Latest entry: FY2026.
1 other company's latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「Total expenses related to research and development activities during the consolidated fiscal year amounted to ¥3,170 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥163 million.」
R&D-related expenses amounted to ¥3,170 million. In the electronics business, the company is making concrete progress in considering the implementation of high-efficiency power electronics, model-based development, EMC, E/E architecture, and OTA in mass-produced products. - FY2026-H1RestatedAnnual report
「Total expenses related to research and development activities during the interim consolidated accounting period amounted to ¥974 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥68 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company recorded ¥974 million in R&D-related expenses, including ¥68 million in R&D expenses under accounting standards, but no material changes were reported in the status of research and development activities. - FY2025AdvancedAnnual report
「Total expenses related to research and development activities during the consolidated fiscal year amounted to ¥2,810 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥183 million.」
R&D-related expenses amounted to ¥2,810 million. In the electronics products business, development efforts have been defined more specifically toward the mass-production implementation of high-efficiency power electronics, model-based development, EMC, power systems, E/E architecture, and OTA. - FY2025-H1RestatedAnnual report
「Total expenses related to research and development activities during the interim consolidated accounting period amounted to ¥1,133 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥80 million. There were no material changes in the status of the Group's research and development activities during the interim consolidated accounting period.」
The company recorded ¥1,133 million in R&D-related expenses, including ¥80 million in R&D expenses under accounting standards. No material changes were reported in the status of research and development activities. - FY2024-Q3RestatedAnnual report
「Total expenses related to research and development activities during the cumulative third quarter amounted to ¥1,439 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥155 million. There were no material changes in the status of the Group's research and development activities during the cumulative third quarter.」
The company recorded ¥1,439 million in R&D-related expenses, including ¥155 million in R&D expenses under accounting standards. No material changes were reported in the status of research and development activities. - FY2024-Q2RestatedAnnual report
「Total expenses related to research and development activities during the cumulative second quarter amounted to ¥871 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥90 million. There were no material changes in the status of the Group's research and development activities during the cumulative second quarter.」
The company recorded ¥871 million in R&D-related expenses, including ¥90 million in R&D expenses under accounting standards. No material changes were reported in the status of research and development activities. - FY2024-Q1RestatedAnnual report
「Total expenses related to research and development activities during the cumulative first quarter amounted to ¥453 million. This amount includes expenses related to the improvement and application of existing products, while R&D expenses as defined under the Accounting Standard for Research and Development Costs, issued by the Business Accounting Council, amounted to ¥45 million. There were no material changes in the status of the Group's research and development activities during the cumulative first quarter.」
The company recorded ¥453 million in R&D-related expenses, including ¥45 million in R&D expenses under accounting standards. No material changes were reported in the status of research and development activities, and the policy on technological innovation remains in place. - FY2023RestatedAnnual report
「Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥2,017 million. R&D expenses included in this amount were ¥191 million.」
The company continues to pursue a policy of treating research and development as its most important management priority for maintaining competitiveness, and recorded ¥2,017 million in R&D-related expenses, including ¥191 million in R&D expenses under accounting standards. Priority themes, including seats, electrical equipment, electronics, power systems, and mobility and welfare equipment, also remain ongoing. - FY2023-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,524 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥132 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,524 million and R&D expenses of ¥132 million under the accounting standards were disclosed. It was stated that there were no material changes in the status of R&D activities. - FY2023-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥1,040 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥88 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥1,040 million and R&D expenses of ¥88 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2023-Q1RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated first quarter amounted to ¥547 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥45 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated first quarter.」
R&D-related expenses of ¥547 million and R&D expenses of ¥45 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2022AdvancedAnnual report
「Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥2,137 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥195 million.」
R&D-related expenses of ¥2,137 million and R&D expenses of ¥195 million under the accounting standards were recognized, and priority themes including power electronics, model-based development and power systems were specified. - FY2022-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,634 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥138 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,634 million and R&D expenses of ¥138 million under the accounting standards were recognized. It was stated that there were no material changes in the status of R&D activities. - FY2022-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥1,096 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥93 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥1,096 million and R&D expenses of ¥93 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2021-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,467 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥141 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,467 million and R&D expenses of ¥141 million under the accounting standards were disclosed. It was stated that there were no material changes in the status of R&D activities, including improvements and applications of existing products. - FY2021-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥939 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥94 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥939 million and R&D expenses of ¥94 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2021-Q1RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated first quarter amounted to ¥453 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥43 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated first quarter.」
R&D-related expenses of ¥453 million and R&D expenses of ¥43 million under the accounting standards were disclosed. It was stated that there were no material changes in the status of R&D activities, including improvements and applications of existing products. - FY2020AdvancedAnnual report
「Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥2,020 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥280 million.」
R&D-related expenses amounted to ¥2,020 million, and R&D expenses under the accounting standards amounted to ¥280 million. Development related to CASE, safety and weight reduction also became more specific, including electric drive power systems, multisound systems and battery backup power supplies. - FY2020-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,501 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥186 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,501 million and R&D expenses of ¥186 million under the accounting standards were disclosed. It was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2020-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥1,016 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥140 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥1,016 million and R&D expenses of ¥140 million under the accounting standards were disclosed. It was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2020-Q1RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated first quarter amounted to ¥491 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥58 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated first quarter.」
R&D-related expenses of ¥491 million and R&D expenses of ¥58 million under the accounting standards were recognized. It was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2019AdvancedAnnual report
「Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥1,903 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥246 million. For electronic units, we commercialized an integrated unit capable of integrated control of various devices, as well as various ECUs for seats, sunroofs, open car roofs and support products accompanying the spread of electrification.」
R&D-related expenses of ¥1,903 million and R&D expenses of ¥246 million under the accounting standards were recognized. Development related to technological innovation became more specific, including the commercialization of integrated units and various ECUs, and products related to electrification and image processing. - FY2019-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,423 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥163 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,423 million and R&D expenses of ¥163 million under the accounting standards were disclosed. It was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2019-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥964 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥120 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥964 million and R&D expenses of ¥120 million under the accounting standards were disclosed. It was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2019-Q1RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated first quarter amounted to ¥502 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥80 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated first quarter.」
R&D-related expenses of ¥502 million and R&D expenses of ¥80 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2018AdvancedAnnual report
「Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥1,832 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥248 million.」
R&D-related expenses of ¥1,832 million and R&D expenses of ¥248 million under the accounting standards were recognized. Specific activities and progress related to technological innovation were added, including the display at the Tokyo Motor Show of development products for future autonomous driving and the acquisition of new orders for electronic products. - FY2018-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,342 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥142 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,342 million and R&D expenses of ¥142 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities. - FY2018-Q1RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated first quarter amounted to ¥450 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥55 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated first quarter.」
R&D-related expenses of ¥450 million and R&D expenses of ¥55 million under the accounting standards were disclosed, and it was stated that there were no material changes in R&D activities, including improvements and applications of existing products. - FY2017RestatedAnnual report
「The Group recognizes research and development as its most important management priority for maintaining corporate competitiveness and is pursuing related initiatives. Total expenses related to research and development activities for the consolidated fiscal year amounted to ¥1,758 million. R&D expenses included in this amount were ¥200 million.」
The policy of treating R&D as the most important management priority continued, and the fiscal-year R&D-related expenses of ¥1,758 million, R&D expenses of ¥200 million under the accounting standards, and specific activities such as product development focused on safety, the environment and comfort were disclosed. - FY2017-Q3RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated third quarter amounted to ¥1,350 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥155 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated third quarter.」
R&D-related expenses of ¥1,350 million and R&D expenses of ¥155 million under the accounting standards were disclosed. The expense amount was updated, but it was stated that there were no material changes in the status of R&D activities. - FY2017-Q2RestatedAnnual report
「Total expenses related to research and development activities for the cumulative consolidated second quarter amounted to ¥906 million. This amount includes expenses related to improvements and applications of existing products, while research and development expenses as defined under the Accounting Standard for Research and Development Costs issued by the Business Accounting Council amounted to ¥95 million. There were also no material changes in the status of the Group’s research and development activities during the cumulative consolidated second quarter.」
R&D-related expenses of ¥906 million and R&D expenses of ¥95 million under the accounting standards were disclosed, while it was stated that there were no material changes in the status of R&D activities related to technological innovation. - FY2017-Q1First statedAnnual report
「“Technological innovation” as a key strategic priority」
It is identified as one of the key strategic priorities under “Ｄream 2020.” No specific technological initiatives or numerical targets are stated.